Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
28.04
-0.91 (-3.14%)
Aug 14, 2026, 12:26 PM EDT - Market open
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $97.46 million as of August 14, 2026. Its market cap has increased by 76.21% in one year.
Market Cap
97.46M
Enterprise Value
73.27M
1-Year Change
76.21%
Ranking
Category
Stock Price
$28.04
ChartMarket Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $97.46M, an increase of 252.03%. That is a compound annual growth rate of 65.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 97.46M | 1.85% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 110.01M |
| Anixa Biosciences | 109.89M |
| Rani Therapeutics Holdings | 109.47M |
| Polaryx Therapeutics | 105.58M |
| ImmuCell | 99.33M |
| Cognition Therapeutics | 98.90M |
| Tenax Therapeutics | 98.52M |
| Oncolytics Biotech | 98.31M |